Abacavir and Lamivudine PK in Children

This study has been completed.
Radboud University
amfAR, Therapeutics Research, Education, and AIDS Training in Asia (TREAT Asia)
PHPT/AMS Laboratory, Faculty of Associated Medical Sciences, Chiang Mai University
Chulalongkorn University
ViiV Healthcare
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
First received: July 17, 2012
Last updated: August 19, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)
Bunupuradah T, Punyahotra P, Cressey TR, Srimuan A, Thammajaruk N, Sophonphan J, Sriheara C, Burger DM, Puthanakit T, Ananworanich J on behalf of the HIV-NAT 167 study team. Plasma pharmacokinetics of once-daily Abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children. Journal of Virus Eradication 2015.